EUVIMEDEUVIMED entdecken
Crossref

Microwave‐Assisted Synthesis and In Vitro Anti‐Alzheimer Evaluation of Novel 1,3,5‐Triazine‐Nicotinic Hydrazide Derivatives as Acetylcholinesterase and Butyrylcholinesterase Inhibitors

Tutumoni Kalita, Anshul Shakya iD, Surajit Kumar Ghosh, Udaya Pratap Singh, Hans Raj Bhat iD

Journal of Biochemical and Molecular Toxicology · 2026

DOI: 10.1002/jbt.70685 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2026. Verfasst von Tutumoni Kalita und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam, India. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Alzheimer Disease, Acetylcholinesterase, Butyrylcholinesterase. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a progressive neurodegenerative disorder posing major global health challenges due to its complex pathophysiology and increasing prevalence among the elderly. In the present work, the molecular hybridization technique was utilized to design and synthesize nicotinic hydrazide‐1,3,5‐triazine hybrids. Accordingly, this study aimed to design, perform in silico screening, synthesize, and evaluate the in vitro and in vivo anti‐AD potential of the proposed compounds. Docking studies revealed that the compounds displayed key interactions with catalytic site and peripheral anionic site residues. Based on binding affinity, ten compounds were synthesized and characterized using different spectroscopic techniques. In vitro AChE and BChE inhibitory assays revealed that the compound 4A36 showed the highest inhibitory ability with log IC 50 values of 5.97 μM against AChE and 4.57 μM against BChE. In addition, cytotoxicity screening revealed that 4A36 was non‐toxic in SH‐SY5Y neuroblastoma cells in the concentration range of 15.625−250 µg/mL. Acute oral toxicity evaluation of the compound revealed no adverse effects up to 175 mg/kg b.w. Further, in vivo studies using the scopolamine‐induced model further validated the therapeutic promise of the compound. At a dose of 30 mg/kg b.w., the compound demonstrated significant improvements in learning and memory, reduced MDA levels with concurrent elevation of antioxidant enzymes SOD and Catalase, and reduced AChE activity in hippocampal tissue. Histopathological observations revealed that treatment groups, especially at higher dose (30 mg/kg b.w.), preserved the granular layer of the dentate gyrus and improved neuronal integrity compared to the disease control. These findings indicate that 4A36 at a dose of 30 mg/kg b.w. may be considered as a promising lead compound in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinesterase InhibitorsAlzheimer DiseaseAcetylcholinesteraseButyrylcholinesteraseTriazinesMicrowavesHydrazinesAnimalsHumansMolecular Docking SimulationCell Line, TumorRatsMale

Stichwörter der Autor:innen

1,3,5‐triazineAChEAlzheimer's diseaseBChEneuroprotectionnicotinic hydrazide

Substanzen

Cholinesterase InhibitorsAcetylcholinesteraseButyrylcholinesteraseTriazinesHydrazines

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam, India.
  • School of Pharmaceutical Sciences, Girijananda Chowdhury University, Hatkhowapara, Azara, Guwahati, Assam, India.
  • Drug Design and Discovery Laboratory, Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture Technology and Sciences, Prayagraj, India.

ORCID-Profile: Anshul Shakya, Hans Raj Bhat

Zitieren

APA

Kalita, T., Shakya, A., Ghosh, S. K., Singh, U. P., & Bhat, H. R. (2026). Microwave‐Assisted Synthesis and In Vitro Anti‐Alzheimer Evaluation of Novel 1,3,5‐Triazine‐Nicotinic Hydrazide Derivatives as Acetylcholinesterase and Butyrylcholinesterase Inhibitors. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70685

Vancouver

Kalita T, Shakya A, Ghosh SK, Singh UP, Bhat HR. Microwave‐Assisted Synthesis and In Vitro Anti‐Alzheimer Evaluation of Novel 1,3,5‐Triazine‐Nicotinic Hydrazide Derivatives as Acetylcholinesterase and Butyrylcholinesterase Inhibitors. Journal of Biochemical and Molecular Toxicology. 2026. doi:10.1002/jbt.70685

BibTeX
@article{Kalita2026,
  author = {Kalita, Tutumoni and Shakya, Anshul and Ghosh, Surajit Kumar and Singh, Udaya Pratap and Bhat, Hans Raj},
  title = {Microwave‐Assisted Synthesis and In Vitro Anti‐Alzheimer Evaluation of Novel 1,3,5‐Triazine‐Nicotinic Hydrazide Derivatives as Acetylcholinesterase and Butyrylcholinesterase Inhibitors},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  doi = {10.1002/jbt.70685}
}
Kostenlos starten →